ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System

Thu Nov 5, 2009 1:19pm EST

* Reuters is not responsible for the content in this press release.

ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood
Glucose Monitoring System

EDINA, Minn., Nov. 5 /PRNewswire/ -- ARKRAY, Inc., the world's 5th largest
manufacturer of diabetes self-monitoring systems, today announced that it has
received 510(k) clearance from the US Food and Drug Administration for its new
GLUCOCARD Vital blood glucose monitoring system.

The new meter and strip platform, which ARKRAY will make available for
distribution in early December, is expected to be a significant complement to
the existing GLUCOCARD line of products, and will be ideal for the home
medical equipment (HME), durable medical equipment (DME), mail order and
managed care markets.

"We're very excited about the latest addition to our GLUCOCARD brand," said
Jonathan Chapman, President of ARKRAY, USA. "The Vital meets all of ARKRAY's
rigorous design and performance standards. And we can offer it at a price
point that will make it an ideal solution for our customers to use in
competitive bidding."

The new GLUCOCARD Vital meter and strip platform is highly accurate,
auto-coded, requires only 0.5 microliter of blood, holds 250 dowloadable tests
in its memory and has a glucose oxydase (GO) strip chemistry that is not
affected by interferences that cause testing errors in other common test

The Vital, along with all GLUCOCARD brands, are backed by ARKRAY's unique
YouChoose((TM)) wellness program, a comprehensive education and support system
that includes printed tools, videos, recipes and an integrated website
designed to help patients manage their diabetes.

ARKRAY manufactures and distributes high-quality, cost-effective products that
are simple, convenient, and easy-to-use, including blood glucose meters, test
strips, safety lancets, and urine chemistry. ARKRAY invests heavily in R&D and
has a strong commitment to high-quality products. For patients, this means
access to cutting-edge, reliable products without sacrificing quality, and
exceptional customer service.

For more information:


Ayme Zemke, +1-651-789-2235,
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.